Diabetic retinopathy and VEGF.

Open Ophthalmol J · 2013 · PMC3580758 · PMID 23459241

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

These anti-VEGF drugs are used as adjunct therapies to laser treatment, but there is an increasing trend towards using them as primary treatment for diabetic macular edema.

also in 63,971 other papers

showed a trendno p-value reported

This 48 patient, multicenter, double-masked, randomized trial studied 3 dose levels of bevasiranib, and showed a trend of decrease in macular thickness between weeks 8 and 12.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.